Media release
From:
Attachments
Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.
Journal/
conference: JAMA
conference: JAMA
Research:Paper
Organisation/s:
Children’s Hospital of Eastern Ontario (CHEO) Research Institute, Canada, Norwegian Institute of Public Health, Norway
Funder:
Study 1 - This study was supported by
funding from the Public Health Agency of Canada,
through the Vaccine Surveillance Reference Group
and the COVID-19 Immunity Task Force. Dr Håberg
was partly funded by the Norwegian Research
Council (project numbers 324312 and 262700).
Study 2 - This research was supported by
the Research Council of Norway (project No.
324312) through its Centres of Excellence funding
scheme (project No. 262700) and by NordForsk
(project No. 105545). Dr Magnus received funding
from the European Research Council under the
European Union’s Horizon 2020 research and
innovation programme (grant No. 947684).